logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Therapeutic enzyme engineering using a generative neural network

delete2022-01-27
delete29
delete
OA
AI
A
Andrew J. Giessel
A
Athanasios Dousis
K
Kanchana Ravichandran
K
Kevin Smith
S
Sreyoshi Sur
I
Iain J. McFadyen
W
Wei Zheng
S
Stuart Licht *
DOI：10.1038/s41598-022-05195-xdelete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Enhancing the potency of mRNA therapeutics is an important objective for treating rare diseases, since it may enable lower and less-frequent dosing. Enzyme engineering can increase potency of mRNA therapeutics by improving the expression, half-life, and catalytic efficiency of the mRNA-encoded enzymes. However, sequence space is incomprehensibly vast, and methods to map sequence to function (computationally or experimentally) are inaccurate or time-/labor-intensive. Here, we present a novel, broadly applicable engineering method that combines deep latent variable modelling of sequence co-evolution with automated protein library design and construction to rapidly identify metabolic enzyme variants that are both more thermally stable and more catalytically active. We apply this approach to improve the potency of ornithine transcarbamylase (OTC), a urea cycle enzyme for which loss of catalytic activity causes a rare but serious metabolic disease.
Keywords:
HUMAN ORNITHINE TRANSCARBAMYLASE
DIRECTED EVOLUTION
PROTEIN
DESIGN
THERMOSTABILITY
MUTATIONS
STABILITY
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Scientific Reports cover
Scientific Reports
IF:
3.9
Papers:
27.8W
Citations:
83.5W

Organization

No organization information available